|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgM, kappa|
|Immunogen||A suspension of human mesotheliema cells from patients with malignant epithelial mesothelioma|
|Storage buffer||tissue culture supernatant|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:25-1:50|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-12220 targets Mesothelioma in IHC (P) applications and shows reactivity with Human samples.
The MA5-12220 immunogen is a suspension of human mesotheliema cells from patients with malignant epithelial mesothelioma.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules.
MA5-12220 was used in immunohistochemistry - paraffin section to investigate using additional markers for core needle biopsy of thyroid nodules.
|Trimboli P,Guidobaldi L,Amendola S,Nasrollah N,Romanelli F,Attanasio D,Ramacciato G,Saggiorato E,Valabrega S,Crescenzi A||Endocrine (52:39)||2016|
Removal of H2A.Z by INO80 promotes homologous recombination.
MA5-12220 was used in immunohistochemistry - paraffin section to investigate H2A.Z removal from chromatin.
|Alatwi HE,Downs JA||EMBO reports (16:986)||2015|
Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
MA5-12220 was used in immunohistochemistry - paraffin section to discuss how to distinguish follicular variant of PTC from other follicular-patterned lesions of the thyroid.
|Ceyran AB,¿enol S,¿im¿ek BÇ,Sa¿¿ro¿lu J,Ayd¿n A||International journal of clinical and experimental pathology (8:3670)||2015|
Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
MA5-12220 was used in immunohistochemistry - paraffin section to study the expression of galectin-3 and HMBE-1 in benign and malignant thyroid tissues in patients
|Abd-El Raouf SM,Ibrahim TR||Pathology, research and practice (210:971)||2014|
Molecular features of follicular variant papillary carcinoma of thyroid: comparison of areas with or without classical nuclear features.
MA5-12220 was used in immunohistochemistry to study cases of follicular variant papilliary carcinoma of the thyroid with and without classical nuclear changes
|Guney G,Tezel GG,Kosemehmetoglu K,Yilmaz E,Balci S,Ersoy R,Cakir B,Guler G||Endocrine pathology (25:241)||2014|
CXC motif ligand 12 as a novel diagnostic marker for papillary thyroid carcinoma.
MA5-12220 was used in immunohistochemistry to study the diagnostic value of the immunohistochemical expression of CXCL12 in papilliary thyroid carcinoma
|Chung SY,Park ES,Park SY,Song JY,Ryu HS||Head and neck (36:1005)||2014|
The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration.
MA5-12220 was used in immunohistochemistry to study the benefits of using core needle biopsy for the diagnosis of thyroid nodules as compared to using fine needle aspiration
|Trimboli P,Nasrollah N,Guidobaldi L,Taccogna S,Cicciarella Modica DD,Amendola S,Romanelli F,Lenzi A,Nigri G,Centanni M,Giovanella L,Valabrega S,Crescenzi A||World journal of surgical oncology (12:null)||2014|
Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique.
MA5-12220 was used in immunohistochemistry to study the ability to discriminate cytologically indeterminate thyroid nodules using thin core biopsies
|Nasrollah N,Trimboli P,Guidobaldi L,Cicciarella Modica DD,Ventura C,Ramacciato G,Taccogna S,Romanelli F,Valabrega S,Crescenzi A||Endocrine (43:659)||2013|
Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
MA5-12220 was used in immunohistochemistry to study the value of the immunohistochemical expression of CK-19, HBME-1 and galectin-3 for distinguishing benign and malignant lesions of the thyroid
|Mataraci EA,Ozgüven BY,Kabukçuoglu F||Polish journal of pathology : official journal of the Polish Society of Pathologists (63:58)||2012|
Primary malignant deciduoid peritoneal mesothelioma: a report of the cytohistological and immunohistochemical appearances.
MA5-12220 was used in immunohistochemistry to investigate deciduoid features of malignant mesothelioma by histomorphological and immunohistochemical evaluation
|Ustun H,Astarci HM,Sungu N,Ozdemir A,Ekinci C||Diagnostic cytopathology (39:402)||2011|
Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19.
MA5-12220 was used in immunohistochemistry to detect malignancies using immunohistochemical markers
|Barut F,Onak Kandemir N,Bektas S,Bahadir B,Keser S,Ozdamar SO||Endocrine pathology (21:80)||2010|
Biphasic malignant mesothelioma cases with osseous differentiation and long survival: a review of the literature.
MA5-12220 was used in immunohistochemistry to report two clinical cases of biphasic malignant mesothelioma with osseous differentiation
|Demirag F,Unsal E,Tastepe I||Lung cancer (Amsterdam, Netherlands) (57:233)||2007|